 SHANGHAI, China and GAITHERSBURG, Md., March 31, 2021 GLOBE NEWSWIRE -- I-Mab the Company Nasdaq: IMAB, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologic, today announced its participation in the following conferences in April. Details of the conferences and management presentation are as follows: 